Brief: Rapt Therapeutics Q2 Net Income USD -27.663 Million
Aug 08 (Reuters) - Rapt Therapeutics Q2 operating income USD -29.33 million. * Q2 basic EPS USD -0.71 * Q2 operating expenses USD 29.33 million
Aug 08 (Reuters) - Rapt Therapeutics Q2 operating income USD -29.33 million. * Q2 basic EPS USD -0.71 * Q2 operating expenses USD 29.33 million